Which weight loss injections carry the least side effects?

What trial data tells us about side-effect rates

The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported that GI side effects were the most common reason participants on tirzepatide reduced or temporarily paused their dose, but the vast majority completed the 72-week programme. Rates of nausea at higher doses ran roughly in the 20–30% range, almost always graded as mild or moderate. In the STEP 1 trial examining semaglutide 2.4mg, the pattern was similar: nausea was common, vomiting less so, and most events were short-lived. Neither trial found a large difference in serious adverse event rates compared with placebo. That context matters. People wondering which weight loss injection has the least side effects often expect a dramatic difference between the two medicines, the honest picture is more nuanced than that.

The NHS tirzepatide page and the equivalent semaglutide entry both list the same broad categories: nausea, vomiting, diarrhoea, constipation, indigestion, burping, fatigue and headache. Injection-site reactions (mild redness or tenderness) are also listed but tend to be minor and brief. Starting at the lowest dose and titrating gradually is the key design feature that keeps these rates manageable; the dose schedule isn't about efficacy in the first weeks, it is about giving your body time to adjust.

How the two injections differ in tolerability

Tirzepatide activates two gut-hormone receptors (GIP and GLP-1), while semaglutide targets one (GLP-1). Whether that dual action meaningfully changes the side-effect experience compared with semaglutide varies by individual. The SURMOUNT-5 head-to-head trial, published in 2025, was designed to compare weight outcomes rather than tolerability specifically, and both medicines produced broadly similar GI adverse-event patterns. A prescriber looking at the full side-effect picture for weight loss injections will consider factors particular to you (your history of GI conditions, any other medicines you take, and whether previous treatment caused problems) rather than applying a blanket rule about which injection is "gentler".

One difference worth knowing: NHS England guidance notes that tirzepatide may reduce the absorption of oral medicines during the weeks after starting or after each dose increase, which is particularly relevant for oral contraceptives. Semaglutide does not carry the same specific warning. This isn't a reason to avoid tirzepatide, but it is worth discussing with a prescriber at the outset. You can read more about the factors that affect which injection suits you on a dedicated comparison page.

When to get medical help

If you are considering or already using a weight loss injection, there are specific symptoms that warrant prompt medical attention rather than watching and waiting. Severe, persistent abdominal pain (especially if it radiates toward the back, with or without vomiting) may suggest acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting this risk; it is uncommon, but it is serious. Seek urgent help if you experience that pattern of pain.

Other situations to contact a doctor or call 111 promptly: signs of a severe allergic reaction (swelling of the face, throat or tongue, difficulty breathing), symptoms of significant dehydration from prolonged vomiting or diarrhoea (dizziness, very dark urine, feeling faint), or jaundice and upper-right abdominal pain that could indicate gallbladder problems. Any sudden changes in vision should also be assessed quickly, particularly if you have diabetes. For a fuller guide to recognising and responding to these symptoms, the NHS medicines information for tirzepatide and the Yellow Card scheme at yellowcard.mhra.gov.uk are both worth bookmarking. Side effects can also be reported there, the data helps the MHRA monitor real-world safety continuously.

Practical ways to reduce day-to-day discomfort

Most of the strategies that reduce GI side effects from weight loss injections are straightforward, even if they require a little adjustment to daily habits. Eating slowly and stopping before feeling completely full helps, because gastric emptying is already slowed by the medicine. Fatty or heavily spiced meals tend to worsen nausea in the early weeks, so keeping meals plain and moderate in size makes a real difference for many people. Staying well hydrated is important, especially if loose stools occur. Some people find injecting in the evening means any peak nausea arrives during sleep, though this is a personal preference rather than a clinical instruction, and your prescriber or the Patient Information Leaflet is the right place to get guidance specific to your situation.

Rotating injection sites across the abdomen, thigh and upper arm reduces localised skin reactions. Letting the pen reach room temperature before use can make injection more comfortable. If you are using a reusable pen or want to stay on top of common questions about treatment, changing the needle for each injection is standard practice. Our team is available seven days a week if something unexpected comes up after you start, that ongoing support is part of what the consultation is built around, not an afterthought. If you would like to talk through suitability and your personal risk factors before committing, starting a free consultation is the natural first step.